Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Trop ; 125(3): 349-56, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23228524

ABSTRACT

The currently available treatments for Chagas disease show limited therapeutic potential and are associated with serious side effects. Our group has been attempting to find alternative drugs isolated from natural products as a potential source of pharmacological agents against Trypanosoma cruzi. Here, we demonstrate the antitrypanosomal activity of the amides piperovatine and piperlonguminine isolated from Piper ovatum against epimastigotes and intracellular amastigotes. We also investigated the mechanisms of action of these compounds on extracellular amastigote and epimastigote forms of T. cruzi. These amides showed low toxicity to LLCMK(2) mammalian cells. By using transmission and scanning electron microscopy, we observed that the compounds caused severe alterations in T. cruzi. These alterations were mainly located in plasma membrane and mitochondria. Furthermore, the study of treated parasites labeled with Rh123, PI and MDC corroborate with our TEM data. These mitochondrial dysfunctions induced by the amides might trigger biochemical alterations that lead to cell death. Altogether, our data evidence a possible autophagic process.


Subject(s)
Antiprotozoal Agents/pharmacology , Autophagy , Dioxolanes/pharmacology , Sorbic Acid/analogs & derivatives , Trypanosoma cruzi/drug effects , Animals , Antiprotozoal Agents/toxicity , Cell Line , Cell Survival/drug effects , Dioxolanes/isolation & purification , Dioxolanes/toxicity , Humans , Microscopy, Electron, Scanning , Microscopy, Electron, Transmission , Organelles/drug effects , Organelles/ultrastructure , Piper/chemistry , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Plant Extracts/toxicity , Sorbic Acid/isolation & purification , Sorbic Acid/pharmacology , Sorbic Acid/toxicity , Trypanosoma cruzi/ultrastructure
2.
Article in English | MEDLINE | ID: mdl-23304195

ABSTRACT

Here we demonstrate the activity of geranylgeraniol, the major bioactive constituent from seeds of Bixa orellana, against Leishmania amazonensis. Geranylgeraniol was identified through (1)H and (13)C nuclear magnetic resonance imaging and DEPT. The compound inhibited the promastigote and intracellular amastigote forms, with IC(50) of 11 ± 1.0 and 17.5 ± 0.7 µg/mL, respectively. This compound was also more toxic to parasites than to macrophages and did not cause lysis in human blood cells. Morphological and ultrastructural changes induced by geranylgeraniol were observed in the protozoan by electronic microscopy and included mainly mitochondria alterations and an abnormal chromatin condensation in the nucleus. These alterations were confirmed by Rh 123 and TUNEL assays. Additionally, geranylgeraniol induces an increase in superoxide anion production. Collectively, our in vitro studies indicate geranylgeraniol as a selective antileishmanial that appears to be mediated by apoptosis-like cell death.

3.
Antimicrob Agents Chemother ; 56(1): 507-12, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22037851

ABSTRACT

American trypanosomiasis, or Chagas' disease, is caused by Trypanosoma cruzi and affects around 15 million people throughout the American continent. The available treatment is based on two nitroheterocyclic drugs, nifurtimox and benznidazole, both only partially effective and toxic. In this context, new drugs must be found. In our previous work, the tetrahydro-ß-carboline compound N-butyl-1-(4-dimethylamino)phenyl-1,2,3,4-tetrahydro-ß-carboline-3-carboxamide, named C4, showed a potent in vitro trypanocidal effect. The goal of this study was to evaluate the in vitro and in vivo trypanocidal effects of the compound C4 associated with other drugs (benznidazole, ketoconazole, and amphotericin B). For this, we used the checkerboard technique to analyze the effect of combinations of C4 reference drugs. C4 was assayed in a murine model alone as well as in association with benznidazole. We also evaluated the parasitemia, mortality, weight, and presence of amastigote nests in cardiac tissue. A synergic effect of C4 plus benznidazole against epimastigote and trypomastigote forms was observed in vitro, and in the murine model, we observed a substantial reduction in parasitemia levels and lowered mortality rates. These findings encourage supplementary investigations of carboline compounds as potential new trypanocidal drugs.


Subject(s)
Carbolines/pharmacology , Chagas Disease/drug therapy , Life Cycle Stages/drug effects , Nitroimidazoles/pharmacology , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Amphotericin B/pharmacology , Animals , Body Weight , Carbolines/chemical synthesis , Cell Count , Cell Line , Chagas Disease/mortality , Chagas Disease/parasitology , Drug Combinations , Drug Resistance , Drug Synergism , Haplorhini , Heart/drug effects , Heart/parasitology , Humans , Ketoconazole/pharmacology , Life Cycle Stages/physiology , Male , Mice , Mice, Inbred BALB C , Survival Rate , Trypanosoma cruzi/growth & development
4.
Microbes Infect ; 13(12-13): 1018-24, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21683800

ABSTRACT

Because of its severe side effects and variable efficacy, the current treatment for Chagas disease is unsatisfactory. Natural compounds are good alternative chemotherapeutic agents for the treatment of this infection. Recently, our group reported the antiproliferative activity and morphological alterations in epimastigotes and intracellular amastigotes of Trypanosoma cruzi treated with eupomatenoid-5, a neolignan isolated from leaves of Piper regnellii var. pallescens. Here, we demonstrate that eupomatenoid-5 exhibited activity against trypomastigotes, the infective form of T. cruzi (EC50 40.5 µM), leading to ultrastructural alteration and lipoperoxidation in the cell membrane. Additionally, eupomatenoid-5 induced depolarization of the mitochondrial membrane, lipoperoxidation and increased G6PD activity in epimastigotes of T. cruzi. These findings support the possibility that different mechanisms may be targeted, according to the form of the parasite, and that the plasma membrane and mitochondria are the structures that are most affected in trypomastigotes and epimastigotes, respectively. Thus, the trypanocidal action of eupomatenoid-5 may be associated with mitochondrial dysfunction and oxidative damage, which can trigger destructive effects on biological molecules of T. cruzi, leading to parasite death.


Subject(s)
Benzofurans/pharmacology , Mitochondria/metabolism , Phenols/pharmacology , Piper/chemistry , Plant Extracts/chemistry , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Benzofurans/chemistry , Benzofurans/isolation & purification , Chagas Disease/drug therapy , Chagas Disease/parasitology , Glucose-6-Phosphate/metabolism , Humans , Hydrogen Peroxide/metabolism , Lignans/chemistry , Lignans/isolation & purification , Lignans/pharmacology , Lipid Peroxidation/drug effects , Membrane Potential, Mitochondrial/drug effects , Mitochondria/drug effects , Mitochondrial Membranes/drug effects , Mitochondrial Membranes/metabolism , Oxidative Stress/drug effects , Phenols/chemistry , Phenols/isolation & purification , Phosphogluconate Dehydrogenase/drug effects , Phosphogluconate Dehydrogenase/metabolism , Plant Leaves/chemistry , Trypanocidal Agents/chemistry , Trypanocidal Agents/isolation & purification , Trypanosoma cruzi/metabolism , Trypanosoma cruzi/ultrastructure
5.
Free Radic Biol Med ; 46(9): 1260-6, 2009 May 01.
Article in English | MEDLINE | ID: mdl-19353782

ABSTRACT

Reactions of tryptophan residues in proteins with radical and other oxidative species frequently lead to cleavage of the indole ring, modifying tryptophan residues into N-formylkynurenine (NFK) and kynurenine. Tryptophan modification has been detected in physiologically important proteins and has been associated with a number of human disease conditions. Modified residues have been identified through various combinations of proteomic analyses, tryptic digestion, HPLC, and mass spectrometry. Here we present a novel, immunological approach using polyclonal antiserum for detection of NFK. The specificity of our antiserum is confirmed using photooxidation and radical-mediated oxidation of proteins with and without tryptophan residues. The sensitivity of our antiserum is validated through detection of NFK in photooxidized myoglobin (two tryptophan residues) and in carbonate radical-oxidized human SOD1, which contains a single tryptophan residue. Analysis of photooxidized milk also shows that our antiserum can detect NFK residues in a mixture of proteins. Results from mass spectrometric analysis of photooxidized myoglobin samples corroborate the immunological data, detecting an increase in NFK content as the extent of photooxidation increases.


Subject(s)
Immunoassay , Kynurenine/analogs & derivatives , Proteins/analysis , Proteins/chemistry , Tryptophan/chemistry , Animals , Antibodies/immunology , Haptens/chemistry , Humans , Immune Sera , Immunization , Kynurenine/analysis , Kynurenine/chemistry , Light , Mass Spectrometry , Milk/chemistry , Myoglobin/analysis , Ovalbumin/chemistry , Oxidation-Reduction , Proteins/immunology , Proteins/metabolism , Rabbits , Sensitivity and Specificity , Superoxide Dismutase/metabolism , Superoxide Dismutase-1 , Tryptophan/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...